Protara Therapeutics, Inc. (TARA)
3.94
-0.03
(-0.76%)
USD |
NASDAQ |
Sep 04, 16:00
3.95
+0.01
(+0.25%)
Pre-Market: 20:00
Protara Therapeutics SG&A Expense (TTM) : 23.56M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.56M |
| March 31, 2026 | 23.01M |
| December 31, 2025 | 21.92M |
| September 30, 2025 | 20.77M |
| June 30, 2025 | 19.86M |
| March 31, 2025 | 18.32M |
| December 31, 2024 | 17.45M |
| September 30, 2024 | 17.30M |
| June 30, 2024 | 17.52M |
| March 31, 2024 | 18.14M |
| December 31, 2023 | 18.62M |
| September 30, 2023 | 18.97M |
| June 30, 2023 | 18.99M |
| March 31, 2023 | 19.72M |
| December 31, 2022 | 20.74M |
| September 30, 2022 | 21.95M |
| June 30, 2022 | 24.18M |
| March 31, 2022 | 25.47M |
| December 31, 2021 | 26.40M |
| September 30, 2021 | 25.49M |
| June 30, 2021 | 21.55M |
| March 31, 2021 | 19.44M |
| December 31, 2020 | 19.99M |
| September 30, 2020 | 16.49M |
| June 30, 2020 | 14.95M |
| Date | Value |
|---|---|
| March 31, 2020 | 10.60M |
| December 31, 2019 | 3.952M |
| September 30, 2019 | 4.870M |
| June 30, 2019 | 5.882M |
| March 31, 2019 | 7.680M |
| December 31, 2018 | 9.524M |
| September 30, 2018 | 9.179M |
| June 30, 2018 | 8.881M |
| March 31, 2018 | 8.736M |
| December 31, 2017 | 8.676M |
| September 30, 2017 | 8.728M |
| June 30, 2017 | 9.082M |
| March 31, 2017 | 9.60M |
| December 31, 2016 | 9.836M |
| September 30, 2016 | 10.01M |
| June 30, 2016 | 9.694M |
| March 31, 2016 | 8.972M |
| December 31, 2015 | 8.489M |
| September 30, 2015 | 7.281M |
| June 30, 2015 | 6.318M |
| March 31, 2015 | 5.339M |
| December 31, 2014 | 4.096M |
| September 30, 2014 | 3.64M |
| June 30, 2014 | 3.279M |
| March 31, 2014 | 3.104M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| NovelStem International Corp. | 0.1201M |
| Brainstorm Cell Therapeutics, Inc. | 6.474M |
| Summit Therapeutics, Inc. | 306.10M |
| Kezar Life Sciences, Inc. | 18.27M |
| Clene, Inc. | 7.873M |